68 /100
MEDIUM RISK
Score updated Feb 26, 2026
GYRE
Gyre Therapeutics, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when GYRE's score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
100
📊 Float Risk
40
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market Cap$820.76M
Shares Outstanding96.33M
Float20.52M
Cash$60.05M
Debt$1.17M
Short InterestN/A
🏛 Institutional Holdings
49 institutional holders · 3.24M shares
#1 VANGUARD GROUP INC 1.15M shares
#2 BlackRock, Inc. 659.4K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 374.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.49M
Days to Cover17.6
% of Float7.3%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Sep 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2018
Full SEC filing analysis available with free account
📰 Recent News
Track GYRE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GYRE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required